Total Payments
$12,213
2024 Payments
$885.20
Companies
18
Transactions
407
Medicare Patients
3,655
Medicare Billing
$280,401
Payment Breakdown by Category
Food & Beverage$7,279 (59.6%)
Consulting$3,580 (29.3%)
Travel$867.23 (7.1%)
Education$486.46 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,279 | 396 | 59.6% |
| Consulting Fee | $3,580 | 2 | 29.3% |
| Travel and Lodging | $867.23 | 2 | 7.1% |
| Education | $486.46 | 7 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $6,694 | 207 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,913 | 43 | $0 (2024) |
| ABBVIE INC. | $730.97 | 32 | $0 (2024) |
| GENZYME CORPORATION | $593.28 | 24 | $0 (2021) |
| UCB, Inc. | $465.27 | 11 | $0 (2024) |
| PFIZER INC. | $403.34 | 23 | $0 (2021) |
| Dermavant Sciences, Inc. | $300.60 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $233.12 | 6 | $0 (2018) |
| Arcutis Biotherapeutics, Inc. | $228.88 | 16 | $0 (2024) |
| Lilly USA, LLC | $154.90 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $885.20 | 59 | Janssen Biotech, Inc. ($344.57) |
| 2023 | $1,333 | 79 | Janssen Biotech, Inc. ($669.01) |
| 2022 | $1,309 | 74 | Janssen Biotech, Inc. ($868.55) |
| 2021 | $908.43 | 45 | Janssen Biotech, Inc. ($474.73) |
| 2020 | $677.14 | 32 | Janssen Biotech, Inc. ($336.29) |
| 2019 | $2,382 | 61 | Novartis Pharmaceuticals Corporation ($1,124) |
| 2018 | $701.05 | 30 | UCB, Inc. ($185.53) |
| 2017 | $4,017 | 27 | Janssen Biotech, Inc. ($3,629) |
All Payment Transactions
407 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Immunology | ||||||
| 09/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 942 | 1,514 | $211,454 | $72,450 |
| 2022 | 9 | 903 | 1,369 | $197,055 | $67,642 |
| 2021 | 13 | 941 | 1,454 | $194,660 | $76,480 |
| 2020 | 12 | 869 | 1,305 | $177,980 | $63,829 |
Total Patients
3,655
Total Services
5,642
Medicare Billing
$280,401
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 301 | 415 | $69,720 | $25,263 | 36.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 128 | $28,928 | $9,885 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 128 | 128 | $24,832 | $9,650 | 38.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 50 | 68 | $23,800 | $8,678 | 36.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 81 | 87 | $20,097 | $5,350 | 26.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 108 | 126 | $17,010 | $4,803 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 45 | $10,710 | $4,100 | 38.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 86 | 487 | $10,227 | $2,379 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,130 | $1,723 | 41.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 16 | $2,000 | $620.52 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 295 | 401 | $67,368 | $25,618 | 38.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 105 | 123 | $27,798 | $9,276 | 33.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 119 | 119 | $23,086 | $8,896 | 38.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 48 | 52 | $16,536 | $6,100 | 36.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 90 | 93 | $21,483 | $5,860 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 63 | $14,994 | $4,488 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 95 | 108 | $14,580 | $4,234 | 29.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 73 | 385 | $8,085 | $2,152 | 26.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 18 | 25 | $3,125 | $1,018 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 334 | $47,047 | $23,768 | 50.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 145 | $28,760 | $12,082 | 42.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 108 | 124 | $28,024 | $9,832 | 35.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 86 | 86 | $16,684 | $7,124 | 42.7% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 41 | 52 | $16,536 | $6,230 | 37.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 81 | 86 | $19,866 | $6,005 | 30.2% |
About Dr. Jay Viernes, MD
Dr. Jay Viernes, MD is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053399477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Viernes, MD has received a total of $12,213 in payments from pharmaceutical and medical device companies, with $885.20 received in 2024. These payments were reported across 407 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($7,279).
As a Medicare-enrolled provider, Viernes has provided services to 3,655 Medicare beneficiaries, totaling 5,642 services with total Medicare billing of $280,401. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 01/05/2006
- Last Updated 05/03/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053399477
Products in Payments
- TREMFYA (Drug) $2,018
- COSENTYX (Biological) $1,533
- REMICADE (Biological) $982.47
- Cimzia (Drug) $439.77
- SKYRIZI (Biological) $420.53
- EUCRISA (Drug) $403.34
- DUPIXENT (Biological) $377.20
- COSENTYX (Drug) $360.55
- VTAMA (Drug) $300.60
- DUPIXENT DUPILUMAB INJECTION (Biological) $233.12
- TALTZ (Drug) $154.90
- DUPIXENT (Drug) $151.63
- Humira (Biological) $151.13
- DERMATITIS - DISEASE (Drug) $144.44
- Skyrizi (Biological) $133.74
- STELARA (Biological) $104.44
- OPZELURA (Drug) $72.50
- Tremfya (Drug) $65.00
- DORYX (Drug) $61.95
- Zoryve (Drug) $55.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608